Our Therapies

The first and only FDA-approved
treatment for Demodex blepharitis

SEC Filing Details

Document Details

Form
Filing Date
November 9, 2022
Document Date
November 9, 2022
Form Description
Report of unscheduled material events or corporate event
Filing Group
Current Reports
Company
Tarsus Pharmaceuticals
Issuer
TARSUS PHARMACEUTICALS, INC.